Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.42
+0.12 (0.78%)
At close: Feb 13, 2026, 4:00 PM EST
15.72
+0.30 (1.95%)
After-hours: Feb 13, 2026, 5:03 PM EST
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.08 billion as of February 13, 2026. Its market cap has increased by 85.40% in one year.
Market Cap
1.08B
Enterprise Value
1.05B
1-Year Change
85.40%
Ranking
Category
Stock Price
$15.42
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.08B, an increase of 739.93%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.06B | -7.86% |
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Day One Biopharmaceuticals | 1.13B |
| Compass Therapeutics | 1.13B |
| MoonLake Immunotherapeutics | 1.11B |
| EyePoint | 1.08B |
| Vir Biotechnology | 1.07B |
| Geron | 1.04B |
| Sana Biotechnology | 1.01B |
| Iovance Biotherapeutics | 1.00B |